Try our Advanced Search for more refined results

CytoDyn Panel Seeks To Reverse $14M Directors Award

By Jeff Montgomery (February 4, 2021, 5:58 PM EST) -- A special litigation committee of the board of life sciences venture CytoDyn Inc. asked Delaware Chancery Court on Wednesday to approve a settlement requiring five directors to forfeit some or all of the 7.2 million shares granted them in 2019, finding no "meaningful" justification for the compensation....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!